This study is testing a medicine called BI 3034701 to see if it helps people living with obesity or overweight to lose weight. You might be able to join if you are between 18 and 74 years old and have a Body Mass Index (BMI) of 30 kg/m² or more, or a BMI of 27 kg/m² or more with at least one weight-related health problem. You can also participate if you haven't been able to lose weight with diet changes. The study will measure the percentage change in your body weight after 42 weeks to see how well BI 3034701 works. The current status of this study is unclear.

Study design

This interventional study plans to enroll 300 participants across 7 groups. Six groups will receive different doses of BI 3034701, and one group will receive a placebo (a substance with no medicine).

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your body weight will be measured at the beginning of the study and again at Week 42 to assess the treatment's effect.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.